JFGIW
Johnson Financial Group Inc (Wisconsin) Portfolio holdings
AUM
$2.22B
1-Year Return
13.66%
This Quarter Return
+5.8%
1 Year Return
+13.66%
3 Year Return
+45.94%
5 Year Return
+69.2%
10 Year Return
+212.62%
AUM
$2.19B
AUM Growth
+$126M
(+6.1%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
55.24%
Holding
1,060
New
238
Increased
337
Reduced
197
Closed
148
Top Buys
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$15.6M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$14.3M |
| 3 |
Invesco S&P 500 Top 50 ETF
XLG
|
+$10.1M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$8.8M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$6.47M |
Top Sells
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$31.6M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$19.9M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$7.73M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$5.1M |
| 5 |
iShares MBS ETF
MBB
|
+$3.79M |
Sector Composition
| 1 | Technology | 8.79% |
| 2 | Consumer Discretionary | 5.02% |
| 3 | Financials | 4.4% |
| 4 | Healthcare | 3.38% |
| 5 | Industrials | 2.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
AtriCure
ATRC
$1.79B
| $3.53K | ﹤0.01% |
+126
| New | +$3.53K |
|
827
BioCryst Pharmaceuticals
BCRX
$1.7B
| $3.53K | ﹤0.01% |
+465
| New | +$3.53K |
|
828
Brookfield Infrastructure
BIPC
$4.78B
| $3.52K | ﹤0.01% |
+81
| New | +$3.52K |
|
829
Ondas Holdings
ONDS
$1.52B
| $3.41K | ﹤0.01% |
4,420
| – | – |
|
830
Agios Pharmaceuticals
AGIO
$2.1B
| $3.38K | ﹤0.01% |
+76
| New | +$3.38K |
|
831
Akamai
AKAM
$11.2B
| $3.33K | ﹤0.01% |
33
+22
| +200% | +$2.22K |
|
832
Ducommun
DCO
$1.34B
| $3.29K | ﹤0.01% |
+50
| New | +$3.29K |
|
833
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
$653M
| $3.25K | ﹤0.01% |
+65
| New | +$3.25K |
|
834
Global X Uranium ETF
URA
$4.28B
| $3.23K | ﹤0.01% |
+113
| New | +$3.23K |
|
835
Schneider National
SNDR
$4.29B
| $3.18K | ﹤0.01% |
111
+89
| +405% | +$2.55K |
|
836
SPDR Portfolio High Yield Bond ETF
SPHY
$9.12B
| $3.18K | ﹤0.01% |
+132
| New | +$3.18K |
|
837
Bank of New York Mellon
BK
$73.9B
| $3.16K | ﹤0.01% |
+44
| New | +$3.16K |
|
838
Markel Group
MKL
$24.4B
| $3.14K | ﹤0.01% |
+2
| New | +$3.14K |
|
839
AstraZeneca
AZN
$252B
| $3.12K | ﹤0.01% |
40
+17
| +74% | +$1.33K |
|
840
Chemours
CC
$2.5B
| $3.11K | ﹤0.01% |
153
| – | – |
|
841
Vale
VALE
$44.2B
| $3.05K | ﹤0.01% |
+261
| New | +$3.05K |
|
842
First Watch Restaurant Group
FWRG
$1.06B
| $3.03K | ﹤0.01% |
+194
| New | +$3.03K |
|
843
Realty Income
O
$54.4B
| $2.98K | ﹤0.01% |
+47
| New | +$2.98K |
|
844
Prudential
PUK
$34.1B
| $2.97K | ﹤0.01% |
+160
| New | +$2.97K |
|
845
La-Z-Boy
LZB
$1.46B
| $2.92K | ﹤0.01% |
+68
| New | +$2.92K |
|
846
Tyler Technologies
TYL
$24.5B
| $2.92K | ﹤0.01% |
+5
| New | +$2.92K |
|
847
Tandem Diabetes Care
TNDM
$845M
| $2.88K | ﹤0.01% |
68
+42
| +162% | +$1.78K |
|
848
Arch Capital
ACGL
$33.9B
| $2.8K | ﹤0.01% |
+25
| New | +$2.8K |
|
849
Avantis Real Estate ETF
AVRE
$644M
| $2.64K | ﹤0.01% |
56
+8
| +17% | +$377 |
|
850
NIO
NIO
$14.1B
| $2.57K | ﹤0.01% |
385
| – | – |
|